← Back to all trials
Recruiting
NCT04272515
Molecular Characterization for Understanding Biliary Atresia
Conditions: Biliary Atresia
Sex: All
Healthy volunteers: Yes
Phase: NA
Enrollment: 100
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France
Location: Hopital Necker enfants malades Paris De
Summary
Although considered a rare disease, Biliary Atresia (BA) is the leading cause of neonatal cholestasis and liver transplantation in children. Little is known about the molecular mechanisms that drive BA. The purpose of this study is to collect the fluid samples, explanted liver tissue samples and dermal biopsy samples to enable investigators to perform the genetic and molecular analyses that might point to the gene(s) and cellular pathway involved in etiology of BA disease.
Eligibility Criteria
Inclusion Criteria:
* confirmed diagnosis of biliary atresia in patients
* parents of BA patients
Exclusion Criteria:
* no
Source: ClinicalTrials.gov (NCT04272515). StuddyBuddy aggregates publicly available trial information.
